Polycystic Ovary Syndrome: Overview and Management

    July 2018 in “ Nursing Clinics of North America ”
    Renate Meier
    Image of study
    TLDR PCOS is a common hormonal disorder in women, marked by symptoms like hair growth and menstrual issues, and requires personalized treatment.
    The document from 2018 provides an overview of Polycystic Ovary Syndrome (PCOS), emphasizing its status as a common endocrine disorder affecting 4% to 12% of women globally and up to 18% in the United States. It details the diagnostic criteria, which include hyperandrogenism and ovulatory dysfunction but not necessarily polycystic ovaries or insulin resistance. The Rotterdam criteria are mentioned for identifying PCOS phenotypes, which are important for assessing chronic disease risk and management. The document also discusses the clinical features of PCOS, such as hirsutism, alopecia, acne, menstrual irregularities, and infertility, as well as associated risks like metabolic syndrome, type 2 diabetes, and mental health disorders. Diagnostic workup involves history, physical examination, laboratory testing, and possibly ultrasonography. Treatment is patient-centered, with oral contraceptives being the first-line treatment for hyperandrogenism symptoms, and clomiphene citrate or letrozole recommended for fertility issues. The document stresses the need for multidisciplinary management and improved education across medical specialties to enhance diagnosis and treatment of PCOS.
    Discuss this study in the Community →

    Research cited in this study

    7 / 7 results

    Related Community Posts Join

    6 / 11 results

      community DHT levels after 4 weeks of Fina and 8 weeks of Fina + 4 weeks of Duta

      in Update  35 upvotes 6 years ago
      The user reported early stage diffuse hair thinning and increased DHT levels after 4 weeks on Finasteride and 8 weeks on Finasteride plus 4 weeks on Dutasteride, despite the medications being authentic and stored properly. They are considering increasing their Dutasteride dosage due to the lack of side effects and are unsure if the treatment is helping their hair.

      community Dutasteride is amazing even for women with FAGA!

      in Female  151 upvotes 6 months ago
      Dutasteride significantly improved hair health and reduced shedding for a woman with PCOS and hyperandrogenism, without causing depression or anxiety, unlike finasteride. Dutasteride also helped with PMDD symptoms and had no side effects, though it changed hair texture.

      community I wish I were a man so bad. Life is cruel

      in Female  219 upvotes 2 weeks ago
      A woman with androgenetic alopecia uses Dutasteride and Bicalutamide but feels devastated due to increased sensitivity to DHT. She considers wigs, Minoxidil, and seeks advice on options like spironolactone, hair transplants, and therapy.

      community Proposed new pathogenesis model for androgenetic alopecia (AGA)

      in Research/Science  8 upvotes 2 years ago
      The conversation discusses a new model for understanding androgenetic alopecia (AGA), linking it to dietary and lifestyle factors similar to PCOS, and highlighting the role of DHT, vascular damage, and inflammation. Treatments mentioned include Minoxidil, finasteride, and RU58841.

    Similar Research

    6 / 1000+ results